Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis

计划入组 1,150 人 · 首次发布于 2025 年 1 月 15 日

Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study

计划入组 1,000 人 · 首次发布于 2025 年 5 月 21 日

Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension

计划入组 40 人 · 首次发布于 2011 年 11 月 16 日

Opal (Cullinan Therapeutics)

Opal

HPK1(Cullinan Oncology, Inc.)

Cullinan Therapeutics

United States

Cullinan Pearl Corp.

United States

Cullinan Mica Corp.

United States

Analysts Maintain Strong Buy Consensus on Cullinan Management (CGEM) with Significant Upside Potential

Cullinan Management's Zipalertinib Shows Promise in NSCLC, Bolstering Stock Rating

Cullinan Therapeutics Reports Promising 30% Response Rate for CLN-049 T Cell Engager in Relapsed AML Patients